Milbemycin Oxime Powder Formula: Tsim cov tshuaj zoo rau tsiaj

Cov tswv tsiaj txhua qhov chaw muaj teeb meem zoo sib xws - yuav ua li cas tiv thaiv lawv cov phooj ywg furry los ntawm cov kab mob tuag taus. Heartworms, roundworms, hookworms thiab mites tuaj yeem ua rau muaj teeb meem kev noj qab haus huv loj uas tuaj yeem cuam tshuam rau tus tsiaj lub neej zoo. Veterinary science muaj ntau cov lus teb rau qhov teeb meem no.Milbemycin Oxime hmoovyog ib qho ntawm cov khoom tseem ceeb hauv kev tswj cov kab mob kom zoo tshaj plaws. Kev nkag siab txog yuav ua li cas cov khoom siv tshuaj no tau hloov pauv mus rau kev kho tsiaj muaj kev nyab xeeb thiab ua tau zoo qhia txog qhov sib npaug ntawm chemistry, kev nyab xeeb thiab kev ua tau zoo uas txawv qhov kev txhim kho kws kho tsiaj tam sim no.

Thaum tsim cov formulation, molecular zog, stability xav tau thiab optimization ntawm bioavailability yuav tsum tau ua tib zoo xav txog. "Kev lag luam kws tshuaj tab tom ntsib cov teeb meem nyuaj los xyuas kom meej tias txhua koob tshuaj muaj kev tiv thaiv zoo ib yam. Hauv kab lus no, peb saib cov kev tshawb fawb uas tom qab milbemycin oxime formulations thiab cov kws kho tsiaj cov tuam txhab tshuaj li cas tsim cov tshuaj uas cov tswv tsiaj tuaj yeem ntseeg tau thiab cov dev yuav muaj kev nyab xeeb rau ib hlis tom qab.

Milbemycin Oxime hmoov

1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) Cov ntsiav tshuaj
Rau dev: 2.3mg / 5.75mg / 11.5mg / 23.0mg
Rau miv: 5.75mg / 11.5mg / 23.0mg
(3) Pill press machine
https://www.achievechem.com/pill-xwm
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
PIB: BM-1-112
Milbemycin Oxime CAS 129496-10-2
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.

Rau tsiaj siv, milbemycin oxime hmoov ua haujlwm zoo heev vim nws muaj cov tshuaj zoo. Qhov no macrocyclic lactone molecule muaj ntau yam khoom uas pab cov kws tshuaj formulator ua cov tshuaj zoo rau cov tsiaj.

Lub cev thiab tshuaj lom neeg ruaj khov

Milbemycin oxime yog qhov ruaj khov thiab yuav nyob twj ywm tiv thaiv kab mob rau lub sijhawm ntev raws li cov xwm txheej khaws cia. Daim ntawv hmoov tso cai rau kev ntsuas yooj yim thiab sib xyaw nrog lwm cov tshuaj, uas yog qhov tseem ceeb rau kev muab cov tshuaj kom zoo rau cov dev ntawm ntau qhov hnyav. Nws cov pleev molecular muaj ob qho tib si lipophilic thiab hydrophilic, yog li thaum noj qhov ncauj nws tau yooj yim nqus los ntawm lub cev. Lub amphipathic xwm ntawm cov tshuaj tso cai rau nws nkag tau yooj yim hla cov kab mob lom thiab ncav cuag cov cab nyob rau hauv ntau seem ntawm lub cev.

Kev nyab xeeb Profile thoob plaws hom

Qhov tshwj xeeb uas ua rau milbemycin oxime tshwj xeeb yog tias nws muaj kev nyab xeeb rau kev siv hauv dev thiab miv. Zoo li qee qhov sib xyaw zoo sib xws, nws tsis nkag mus tob rau hauv lub hlwb ntawm cov tsiaj thaum tswj hwm kom txaus. Cov yam ntxwv no txo ​​cov teeb meem cuam tshuam rau lub paj hlwb, yog li nws tuaj yeem siv rau hauv cov tsiaj txhu uas muaj kev cuam tshuam rau qee yam kab mob parasiticides. Kev tshawb nrhiav tshuaj toxicology tau pom qhov dav kho qhov ntsuas ntawm milbemycin oxime. Qhov no qhia txog qhov tseem ceeb ntawm kev nyab xeeb ntawm kev noj tshuaj uas muaj txiaj ntsig zoo thiab qib uas txaus ntshai. Qhov no ua rau nws muaj kev nyab xeeb siv nrog tsiaj.

Compatibility nrog Formulation Excipients

Cov neeg tsim tshuaj siv tau zoo siab tias milbemycin oxime tuaj yeem ua ke nrog ntau yam tshuaj inert uas feem ntau siv hauv cov ntsiav tshuaj, chewable thiab cosmetic cov ntaub ntawv. Cov hmoov sib xyaw ua ke zoo nrog cov stabilizers, flavorings thiab binding agents yam tsis muaj kev cuam tshuam cov tshuaj muaj zog uas yuav txo tau nws cov txiaj ntsig. Qhov no ua rau cov tuam txhab tsim khoom ntau yam khoom kom haum rau ntau lub khw. Piv txwv li, lawv tuaj yeem tsim cov chewables uas dev yuav zoo siab lick los yog cov ntsiav tshuaj uas tuaj yeem ua rau hnyav.

Paub txog cov molecular ua-li ntawm milbemycin oxime hmoov pab koj nkag siab txog nws cov txiaj ntsig zoo ntawm cov tshuaj tiv thaiv kab mob thiab vim li cas nws tau dhau los ua cov khoom muaj npe nrov hauv cov tshuaj kho tsiaj.

Molecular Structure thiab Mechanism

MMilbemycin oxime yog ib qho kev sib xyaw ntawm cov molecules zoo sib xws nyob rau hauv ib qho kev faib ua feem, feem ntau yog milbemycin A4 oxime thiab milbemycin A3 oxime. Cov tebchaw hauv chav kawm no yog macrocyclic lactones. Lawv muaj cov ntaub ntawv loj loj uas cuam tshuam nrog cov kab mob parasite neurotransmission. Cov tshuaj tshwj xeeb khi rau glutamate-gated chloride channels tam sim no nyob rau hauv invertebrate paj hlwb thiab cov leeg hlwb. Qhov kev khi no nce permeability ntawm daim nyias nyias mus rau chloride ions thiab yog li tus nqi ntawm cov cell membrane. Qhov no ua rau cov kab mob tuag tes tuag taw, thiab thaum kawg tua lawv.

Spectrum ntawm Antiparasitic Activity

milbemycin oxime tua ntau yam kab mob xws li cab thiab arthropods yog li nws tiv thaiv ntau yam sib txawv. Nws tua cov kab mob plawv (Dirofilaria immitis) ua ntej lawv loj hlob mus rau cov kab mob laus thiab ua rau muaj kab mob tuag taus.

Cov tshuaj no kuj zoo heev tiv thaiv kab mob plab hnyuv xws li Toxocara spp., hookworms xws li Ancylostoma caninum thiab whipworms xws li Trichuris vulpis. Milbemycin oxime muaj txiaj ntsig zoo tiv thaiv kab mob sab hauv thiab ntau hom kab mob xws li Sarcoptes thiab Demodex hom. Qhov no ua rau nws muaj txiaj ntsig zoo hauv cov haujlwm uas tswj txhua yam kab mob.

Selective Toxicity Advantage

Ib qho laj thawj uas yog vim li cas milbemycin oxime tseem ceeb hauv cov tshuaj yog tias nws yog ib qho tshuaj lom neeg xaiv, piv txwv li, nws muaj txiaj ntsig zoo hauv nws qhov kev txiav txim ntawm cov kab mob cab tab sis tsis zoo heev hauv nws qhov kev ua ntawm cov tsiaj.

Qhov no yog vim hais tias cov qauv ntawm neurotransmitter receptors txawv nyob rau hauv invertebrates thiab vertebrates. Cov tsiaj nyeg muaj glutamate gated chloride channels feem ntau nyob rau hauv lub hauv nruab nrab paj hlwb tiv thaiv los ntawm cov ntshav hlwb barrier. Ntawm kev kho mob ntau, milbemycin oxime tsuas yog me ntsis hla qhov teeb meem no thiab vim li no feem ntau zam cov tswv tsev cov ntaub so ntswg, thaum tseem tua cov kab mob. Veterinarians nyiam qhov no vim tias nws muaj txiaj ntsig zoo -rau- pheej hmoo profile.

Qhov zoo thiab cov yam ntxwv ntawm cov khoom siv tshuaj nquag muaj qhov cuam tshuam ncaj qha rau cov khoom lag luam kws kho tsiaj ua tiav zoo li cas. Muaj ntau ntau yam ntawm qhovmilbemycin oxime hmoovnws tus kheej cuam tshuam cov tshuaj zoo npaum li cas thaum kawg.

Purity thiab Potency Standards

Txhawm rau kom ntseeg tau tias cov txiaj ntsig tau zoo ib txwm zoo ib yam, cov tshuaj -qib milbemycin oxime yuav tsum tau ua raws li cov kev cai nruj. Cov khoom tsis huv lossis cov khoom tawg tuaj yeem ua rau qee yam tsis zoo thiab tuaj yeem ua rau muaj kev phom sij. High-Kev ua tau zoo ntawm cov kua chromatography (HPLC) thiab lwm yam kev tshuaj ntsuam xyuas kom paub tseeb tias txhua pawg ntawm cov hmoov muaj cov nqi ntawm milbemycin A4 thiab A3 oximes thiab lwm yam tshuaj tsawg heev. Kev ntsuam xyuas cov khoom muaj zog lub zog, uas feem ntau yog muab raws li ib feem ntawm nws qhov siab tshaj plaws, ua kom paub tseeb tias nws tseem muaj cov tshuaj tiv thaiv kab mob. Rau cov chaw tsim khoom nrog GMP daim ntawv pov thawj los ua kom cov qauv no hla kev tsim khoom,

lawv siv txoj kev tswj kom zoo.

Particle Loj Distribution

Dissolution tus nqi thiab bioavailability yog cuam tshuam los ntawm lub cev zoo ntawm milbemycin oxime hmoov, tshwj xeeb tshaj yog particle loj. Cov khoom me me feem ntau muaj ntau qhov chaw uas tuaj yeem yaj hauv plab acid, uas tuaj yeem ua kom nqus tau zoo dua. Txhawm rau kom tau txais txiaj ntsig zoo tshaj plaws, cov kws tsim tshuaj tshuaj feem ntau sau cov kab lus me me. Cov txheej txheem Micronization tuaj yeem siv los ua cov khoom me me, tab sis qhov no yuav tsum tau ntsuas qhov nws yuav cuam tshuam rau cov hmoov ruaj khov thiab muaj peev xwm ntws. Kev faib tawm qhov loj me sib xws ua kom paub tseeb tias cov koob tshuaj muaj cov tshuaj tib yam thiab cov tshuaj pharmacokinetic profiles tau ntseeg tau.

Crystalline Form Considerations

Milbemycin oxime tuaj yeem muaj nyob hauv cov ntaub ntawv crystalline sib txawv, uas yog hu ua polymorphs. Qhov no tshwm sim rau ntau cov tshuaj sib txuas. Cov kev sib txawv ntawm cov qauv no yuav qhia tau ntau yam kev sib cais, cov qauv ruaj khov, thiab kev ua haujlwm zoo. Polymorph kev tshuaj xyuas thiab kev xaiv yog siv rau hauv kev tshawb fawb tshuaj los nrhiav daim ntawv uas zoo tshaj plaws rau ob qho tib si ua cov tshuaj thiab ua haujlwm zoo hauv cov khoom muaj sia. Kev tswj cov khoom siv thaum lub sij hawm tsim khoom thiab khaws cia nres cov kev hloov pauv uas tuaj yeem tshwm sim ntawm xiav thiab hloov cov tshuaj ua haujlwm li cas lossis ntev npaum li cas. Ua tib zoo saib xyuas cov khoom noj khoom haus- xeev chemistry yog ib feem tseem ceeb ntawm kev tsim cov kev tshawb fawb uas muaj kev cuam tshuam ncaj qha rau qhov zoo ntawm qhov tshwm sim.

Tau txais cov hmoov milbemycin oxime kom sib npaug sib npaug hauv daim ntawv ntau npaum yog qhov nyuaj rau kev ua haujlwm, tab sis cov kws tshawb fawb kws kho mob tuaj yeem ua tau zoo los ntawm kev npaj ua tib zoo npaj.

Blending thiab Mixing Techniques

Thaum milbemycin oxime hmoov yog tov nrog lwm cov khoom xyaw thaum lub sij hawm blending txheej txheem, homogeneous tis pib. Vim yog qhov me me ntawm cov khoom xyaw nquag piv rau tag nrho qhov hnyav ntawm qhov sib tov, nws yuav tsum tau tov nrog cov cuab yeej tshwj xeeb thiab cov txheej txheem. Nyob ntawm cov khoom sib tov, V-benders, spin blenders, lossis siab -shear mixers yuav raug siv. Blending validation cov kev tshawb fawb qhia tau hais tias txhua chav tsev ntau npaum li cas muaj cov active ingredient nyob rau hauv nruj txwv. Rau cov ntsiab lus kev sib piv kom dhau, cov qauv feem ntau yuav tsum tau los ntawm ntau qhov sib xyaw.

Excipient xaiv rau cov ntsiab lus Uniformity

Kev xaiv ntawm cov khoom xyaw uas tsis muaj zog muaj qhov cuam tshuam loj npaum li cas milbemycin oxime kis tau zoo thiab nyob twj ywm. Nws yog ib qho tseem ceeb uas yuav tau xaiv cov diluents, binders, thiab glidants uas ua haujlwm zoo nrog cov khoom muaj txiaj ntsig lub cev. Diluents xws li microcrystalline cellulose, lactose, los yog cov hmoov txhuv nplej siab hloov pauv feem ntau yog siv los ntxiv ntau thiab ua kom zoo dua. Cov me me ntawm colloidal silicon dioxide los yog magnesium stearate tuaj yeem muab ntxiv kom cov hmoov tsis sib koom ua ke thiab kom paub tseeb tias nws ntws zoo thaum cov ntsiav tshuaj lossis tshuaj ntsiav tau ntim lossis ntim. Thaum lub sij hawm kev tsim kho, qhov piv thiab hom excipients yog tweaked kom tau txais kev txhim khu kev qha ntau lawm uas ib txwm ua tau siab - cov khoom zoo.

Manufacturing txheej txheem tswj

Hauv kev tsim tshuaj niaj hnub no, cov txheej txheem kev tshuaj ntsuam xyuas yog siv los saib xyuas cov yam ntxwv tseem ceeb thoob plaws hauv kev sib xyaw ntawm cov tshuaj. Hauv - kab lossis ntawm - kab kev sim tso cai rau koj tshuaj xyuas tej yam xws li kev sib xyaw ua ke, cov ntsiav tshuaj nyuaj, yaj cov ntaub ntawv thiab ntau yam tsis tau tos rau kev tshuaj ntsuam xyuas dav dav. Cov kev ntsuas no hauv lub sijhawm tiag tiag - tso cai rau kev hloov kho tam sim los tswj cov khoom hauv spec. Cov txheej txheem tswj xyuas cov kab kos saib xyuas cov cim tseem ceeb nyob rau lub sijhawm thiab tshawb nrhiav cov ncauj lus uas yuav qhia tau tias cov cuab yeej hnav tawm lossis cov khoom siv raw hloov pauv ua ntej lawv cuam tshuam cov khoom zoo. Qhov kev tswj xyuas zoo tshaj plaws no tau lees paub tias txhua lub ntsiav tshuaj lossis chewable uas muaj milbemycin oxime muab cov koob tshuaj kom tsim nyog.

Ob peb kauj ruam yuav tsum tau tig rawmilbemycin oxime hmoovmus rau hauv ib tug tiav veterinary tshuaj. Txhua kauj ruam cuam tshuam txog kev nyab xeeb, kev ua tau zoo, thiab saj ntawm cov khoom kawg.

Dosage Form Development

Nyob ntawm seb hom tsiaj twg, nws yuav tsum tau txhaj ntau npaum li cas, thiab nws yooj yim npaum li cas rau tus tswv, cov kws kho mob xaiv cov ntaub ntawv kho mob. Cov ntsiav tshuaj tuaj yeem siv rau qhov hnyav - raws li cov txheej txheem tswj hwm vim tias lawv muaj cov koob tshuaj kom raug thiab lub neej txee ntev. Cov ntaub ntawv chewable siv flavorings thiab texturizing tshuaj uas ua rau tib neeg xav noj lawv, uas ua rau kom muaj kev koom tes. Cov tshuaj pleev xim yog ib qho kev xaiv rau cov miv uas tsis xav noj tshuaj. Piv txwv li, chewables yuav tsum tau ua tib zoo tswj qhov ntub dej kom lawv cov qauv, thiab cov khoom siv tshuaj pleev ib ce yuav tsum xyuas kom meej tias lawv tuaj yeem nkag mus tob rau hauv daim tawv nqaij yam tsis ua rau nws khaus.

Kom paub tseeb tias cov tsiaj yuav yooj yim txais cov tshuaj, pab pawg txhim kho sim nws saj ntawm hom hom phiaj.

Kev ntsuas kev ruaj ntseg thiab kev txiav txim siab lub neej txee

Cov koom haum tswj hwm xav tau ntau cov ntaub ntawv ruaj khov los qhia tias cov tshuaj tsiaj khaws lawv cov txiaj ntsig zoo rau tag nrho lub sijhawm uas tau sau rau ntawm daim ntawv lo thiab thaum lawv khaws cia rau hauv ib txoj kev. Txhawm rau txheeb xyuas seb milbemycin oxime formulations yuav coj li cas rau lub sijhawm ntev, kev tshawb fawb nrawm nrawm ua rau lawv kub thiab av noo. Tiag - cov kev tshawb fawb ruaj khov lub sijhawm khaws cov khoom muag uas khaws cia rau hauv ib txwm muaj li peb xyoos.

Kev tshuaj ntsuam xyuas yog ua tiav ntawm lub sijhawm teem sijhawm los kuaj xyuas cov khoom xyaw nquag, cov khoom tawg, kev saib lub cev, thiab rhuav tshem cov ntaub ntawv. Qhov kev ntsuam xyuas zoo no teev cov hnub tas sij hawm thiab cov txheej txheem khaws cia uas ua kom cov tswv tsev tau txais cov tshuaj zoo rau ntev npaum li cov khoom lag luam nyob hauv khw.

Quality Assurance thiab Regulatory Compliance

Ua ntej lawv mus muag, cov khoom siv tshuaj tiav tau dhau los ntawm ntau qhov kev kuaj xyuas zoo. Cov kev ntsuam xyuas qhia tau hais tias txhua batch muaj tus nqi ntawm milbemycin oxime uas tau sau rau ntawm daim ntawv lo, uas yog nyob rau hauv kev txwv. Kev tshuaj ntsuam xyuas kom paub tseeb tias cov khoom xyaw nquag tso tawm ntawm tus nqi zoo los ntawm cov ntsiav tshuaj lossis chewables.

Kev ntsuam xyuas microbiological ua kom cov khoom ua tau raws li qhov yuav tsum tau ua rau bioburden lossis purity. Kev Tswj Xyuas Kev Tswj Xyuas Zoo tau teeb tsa los ntawm cov pab pawg xws li Lub Tsev Haujlwm Saib Xyuas Tshuaj European lossis FDA Lub Chaw Rau Cov Tshuaj Kho Mob yuav tsum ua raws li cov chaw tsim tshuaj rau tsiaj. Kev kuaj xyuas tsis tu ncua ua kom paub tseeb tias cov txheej txheem tsim khoom, kev tswj xyuas zoo, thiab lawv cov ntaub ntawv li cas yog tag nrho cov cai, uas ua rau cov neeg siv khoom ntseeg siab tias cov khoom muaj kev nyab xeeb thiab siv tau zoo.

Kev loj hlob ntawmmilbemycin oxime hmoovrau hauv cov tshuaj muaj txiaj ntsig zoo qhia tau hais tias txoj kev tshawb fawb nyuaj npaum li cas tom qab cov tshuaj kho tsiaj tam sim no. Kev nkag siab txog cov txheej txheem molecular thiab txhim kho cov txheej txheem tsim khoom yog txhua feem ntawm cov qauv tsim uas nkag mus rau hauv cov tshuaj uas ua rau cov tsiaj tsis txhob kis kab mob uas tuaj yeem ua rau lawv mob. Milbemycin oxime lub cev thiab tshuaj lom neeg cov khoom tso cai rau cov neeg tsim khoom tsim ntau hom khoom uas txhua tus muaj tib theem kev nyab xeeb thiab ua haujlwm tau zoo.

Cov tshuaj tiv thaiv kab mob tshiab yuav ua raws li cov hauv paus ntsiab lus uas tswj kev tsim ntawm milbemycin oxime raws li cov kws kho tsiaj txuas ntxiv txhim kho. Milbemycin oxime yog ib qho qauv molecule vim nws tawm tsam kev sib xyaw ua ke ntawm qhov dav -spectrum kev txiav txim, xaiv toxicity, thiab yooj yim ntawm kev tsim khoom. Cov tswv tsiaj tuaj yeem tau txais txiaj ntsig los ntawm qhov kev tsim kho tshuaj tshiab no vim tias nws ua rau lawv ntseeg tau, yooj yim - rau - siv cov tshuaj uas pab ua kom lawv cov tsiaj noj qab haus huv thiab tsis muaj kab mob.

Bloomtechz yog lub tuam txhab koj tso siab tau los muab koj cov tshuaj - qibmilbemycin oxime hmoov. Peb muab siab -purity milbemycin oxime hmoov rov qab los ntawm cov pov thawj scientific, suav nrog HPLC, LC-MS, thiab HNMR pov thawj. Peb muaj ntau tshaj 15 xyoo ntawm kev paub nyob rau hauv organic synthesis thiab tshuaj intermediates. Teb Chaws Asmeskas -FDA, CFDA, PMDA, thiab EU cov cai tswjfwm tau ua tib zoo tshuaj xyuas peb cov GMP- cov chaw muaj ntawv pov thawj, ua kom txhua pawg ua tau raws li cov qauv zoo tshaj plaws thoob ntiaj teb. Peb pab neeg ua haujlwm muaj kev txawj ntse los ua kom koj cov kws kho tsiaj ua haujlwm, txawm tias koj xav tau API loj rau kev tsim khoom lag luam lossis pab tsim cov qauv tsim tshwj xeeb. Peb paub tias nws tseem ceeb npaum li cas rau cov tshuaj tiv thaiv kab mob kom ib txwm ua tau zoo, yog li peb muaj kev tswj xyuas nruj nyob rau hauv qhov chaw thoob plaws peb cov saw hlau tag nrho. Email peb pab neeg muag khoom ntawmSales@bloomtechz.comtam sim no los tham txog koj cov kev xav tau ntawm milbemycin oxime hmoov thiab nrhiav seb peb cov nqi qis thiab cov sij hawm xa tuaj zoo li cas tuaj yeem pab koj txoj kev lag luam loj hlob.

1. Campbell, WC, thiab Benz, GW (1984). "Ivermectin: Kev Tshawb Fawb Txog Kev Ua Haujlwm thiab Kev Nyab Xeeb." Phau ntawv Journal of Veterinary Pharmacology thiab Therapeutics, 7(1), 1-16.

2. Prichard, RK, thiab al. (2012). "Cov Txheej Txheem Kev Tshawb Fawb rau Helminth Tshuaj Tiv Thaiv hauv Veterinary Medicine." Trends in Parasitology, 28(7), 294-300.

3. Shoop, WL, et al. (1995). "Mechanism of Action thiab Resistance to Macrocyclic Lactone Anthelmintics in Parasites." Tam sim no Pharmaceutical Biotechnology, 6(3), 211-223.

4. McKellar, QA, and Benchaoui, HA (1996). "Avermectins thiab Milbemycins hauv Veterinary Medicine." Phau ntawv Journal of Veterinary Pharmacology thiab Therapeutics, 19(5), 331-351.

5. European Medicines Agency. (2010). "Cov Lus Qhia Txog Kev Txhim Kho Tshuaj ntawm Veterinary Medicines." Pawg Neeg Saib Xyuas Kev Kho Mob rau Kev Siv Veterinary, London.

6. Npis Sov, BF, et al. (2000). "Pharmacokinetics ntawm Milbemycin Oxime hauv dev: Qhov cuam tshuam rau kev siv tshuaj kho mob." American Journal of Veterinary Research, 61(4), 482-486.